Ensign Peak Advisors, Inc - RHYTHM PHARMACEUTICALS INC ownership

RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 128 filers reported holding RHYTHM PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.30 and the average weighting 0.1%.

Quarter-by-quarter ownership
Ensign Peak Advisors, Inc ownership history of RHYTHM PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$425,259
+59.2%
18,550
+14.5%
0.00%0.0%
Q2 2023$267,138
-91.5%
16,200
-85.1%
0.00%
-85.7%
Q4 2022$3,161,325
+1053.8%
108,562
+871.9%
0.01%
+600.0%
Q3 2022$274,000
+124.6%
11,170
-61.9%
0.00%
Q2 2022$122,000
+106.8%
29,345
+476.5%
0.00%
Q1 2022$59,000
+15.7%
5,0900.0%0.00%
Q4 2021$51,000
-93.6%
5,090
-87.6%
0.00%
-100.0%
Q2 2021$801,000
-7.9%
40,8910.0%0.00%0.0%
Q1 2021$870,000
+38.3%
40,891
+93.1%
0.00%
+100.0%
Q4 2020$629,000
+37.0%
21,1730.0%0.00%0.0%
Q3 2020$459,00021,1730.00%
Other shareholders
RHYTHM PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 909,258$10,475,0003.58%
NEA Management Company, LLC 4,912,306$56,590,0001.64%
RA Capital Management 4,871,067$56,115,0001.22%
Pinz Capital Management, LP 148,475$1,710,0001.07%
Samsara BioCapital, LLC 345,293$3,978,0001.00%
Bell & Brown Wealth Advisors, LLC 117,400$1,352,0000.61%
Rock Springs Capital Management LP 1,237,026$14,251,0000.36%
ACT CAPITAL MANAGEMENT, LLC 27,500$317,0000.34%
Endurant Capital Management LP 105,792$1,219,0000.32%
Baker Brothers Advisors 4,125,062$47,521,0000.27%
View complete list of RHYTHM PHARMACEUTICALS INC shareholders